Search the Newsreel

Assenagon Asset Management S.A. Acquires 4,334 Shares of Quest Diagnostics Incorporated $DGX

Assenagon Asset Management S.A. increased its stake in Quest Diagnostics Incorporated by 39.1% in the second quarter, acquiring 4,334 shares and bringing its total holdings to 15,405 shares valued at approximately $3.27 million. The medical research company reported strong Q2 earnings, exceeding estimates with …

Quest Diagnostics Inc (DGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Quest Diagnostics Inc (DGX), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that DGX has a momentum score of 3.90, trading between resistance at $249.41 and support at $213.38. The …

Quest Diagnostics Incorporated (NYSE:DGX) Plans Quarterly Dividend of $0.86

Quest Diagnostics (NYSE:DGX) has declared a quarterly dividend of $0.86 per share, payable on October 21st to shareholders of record on October 6th. This dividend represents an annualized payout of $3.44 and a 1.4% yield. The company has a strong dividend history, having increased …

Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6

Quest Diagnostics (DGX) announced that it will maintain its quarterly dividend at $0.86 per share. This dividend will be payable on October 21, 2026, to shareholders of record as of October 6, 2026. The announcement was published on August 12, 2026, by MT Newswires.

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J., Aug. 12, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on October 21, 2026 to shareholders of record of Quest …

Quest Diagnostics Sets Oct. 21 Date for Cash Dividend

Quest Diagnostics (NYSE: DGX) has announced a quarterly cash dividend of $0.86 per share. The dividend will be payable on October 21, 2026, to shareholders of record as of October 6, 2026. This move reflects the company's commitment to providing direct cash returns to …

Quest Diagnostics Incorporated (DGX) stock price, news, quote and history

Insight Molecular Diagnostics: Q2 Earnings Snapshot

The provided content is not an article but rather a privacy notice or a placeholder. It does not contain any information about Insight Molecular Diagnostics or its Q2 earnings. Therefore, no meaningful summary can be generated.

IVY LANE CAPITAL MANAGEMENT, LLC's Quest Diagnostics Inc(DGX) Holding History

This article details IVY LANE CAPITAL MANAGEMENT, LLC's historical holdings in Quest Diagnostics Inc (DGX). As of March 31, 2026, the firm holds 29,000 shares valued at $5.68 million, representing 8.59% of its portfolio. The investment has generated an estimated gain of $4.19 million, …

Quest Diagnostics Incorporated (QDI.F) Stock Price, News, Quote & History

Quest Diagnostics Inc (DGX) Stock News Today

This article from TradingKey provides a news page for Quest Diagnostics Inc (DGX) stock. It includes current stock performance metrics like price, market cap, and P/E ratio. The page indicates that more news will be coming soon regarding DGX stock.

The Bull Case For Quest Diagnostics (DGX) Could Change Following Raised Guidance And New Self-Collection Services

Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC

Empowered Funds LLC significantly reduced its stake in Quest Diagnostics (NYSE:DGX) by 61.5% in the first quarter, selling over 15,000 shares. Despite this, institutional investors still own a substantial 88.06% of the company's stock. Quest Diagnostics exceeded Q1 earnings and revenue expectations, and analysts …

Quest Diagnostics Inc. stock outperforms competitors on strong trading day

Shares of Quest Diagnostics Inc. rose 1.13% to $238.50 on a strong trading day, outperforming the S&P 500 Index and the Dow Jones Industrial Average, both of which experienced declines. This marks the third consecutive day of gains for the stock.

Arrowstreet Capital Limited Partnership Purchases New Shares in Quest Diagnostics Incorporated $DGX

Arrowstreet Capital Limited Partnership initiated a new position in Quest Diagnostics (NYSE:DGX) by acquiring 11,468 shares valued at approximately $2.25 million. This move comes as institutional investors now own 88.06% of the company, and several analysts have raised price targets following Quest Diagnostics' strong …

Is Quest Diagnostics (DGX) A Bargain Following Raised Guidance And Strong Quarterly Results?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Quest Diagnostics (DGX) has drawn fresh attention after raising its full year 2026 revenue and earnings guidance, alongside reporting second quarter results that showed …

Quest Diagnostics (DGX) Stock May Be 32% Undervalued As Guidance Rises

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Quest Diagnostics stock has climbed strongly over the past few years, yet current valuation checks suggest the shares may still trade below an estimate …

Quest Diagnostics (DGX) Lifts 2026 Outlook As Investors Ask If The Stock Is Fully Valued

Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates

Quest Diagnostics (DGX) has increased its 2026 revenue and adjusted earnings guidance, attributing the improved outlook to accelerated testing demand across various channels. While the company's Q2 results exceeded expectations, driven by volume growth, concerns remain regarding the impact of lower-margin partnerships and increased …

DGX|Quest Diagnostics Inc|Price:233.010|Chg%:-1.190

This article provides an overview of Quest Diagnostics Inc. (DGX), detailing its current stock performance, key financial figures, and analyst ratings. The company is highlighted for its healthy fundamentals, high growth potential, and strong institutional ownership, with analysts generally rating it as a "Buy" …

Quest Diagnostics Incorporated (DGX) jumps 8.2% as volume nearly doubles

The diagnostics stock’s weekly advance gained confirmation from heavier turnover and positive momentum readings.

Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?

Quest Diagnostics Incorporated DGX has rallied as earnings momentum improved, estimates moved higher and demand broadened across its testing platform. The buy case is not one-sided. The stock's advance has lifted valuation closer to its five-year high, while leverage, cost pressure and reimbursement uncertainty …

Quest Diagnostics’ 8.6M-share advance tightens the chase toward its 52-week high

DGX gained 8.2% in the latest week on twice its 13-week volume average, leaving the clinical-lab stock 4.2% below its 52-week high while valuation and reversal risk argue for confirmation.

Argus Research Adjusts Quest Diagnostics Price Target to $260 From $225, Maintains Buy Rating

Argus Research has increased its price target for Quest Diagnostics (DGX) to $260 from $225, while reiterating a Buy rating on the stock. This adjustment reflects a positive outlook on the company's future performance. The article also notes other recent analyst adjustments for Quest …

Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026

Quest Diagnostics (DGX) is propelled by broad testing demand, expanded payer access, advanced diagnostics, and strategic partnerships, supporting revenue growth in 2026. The company's base business benefits from physician, hospital, and consumer channels, while advanced diagnostics in multiple health areas and acquisitions contribute significantly. …

Labcorp raises annual profit forecast on strong testing demand

By Sahil Pandey July 30 (Reuters) - Laboratory operator Labcorp raised its annual profit forecast and posted better-than-expected second-quarter results on Thursday, ‌as steady demand for diagnostic testing and growth in ‌its drug-development services business boosted performance. Shares of the company fell about 6% …

Bacterial vaginosis patients were over 3x more likely to have an STI

A national study by Quest Diagnostics and Hologic, analyzing data from over 1.5 million U.S. women, found that 12% of women positive for bacterial vaginosis (BV) also had at least one non-viral sexually transmitted infection (STI), compared to 3.8% of BV-negative women. BV positivity …

QUEST DIAGNOSTICS INC : JP MORGAN RAISES TARGET PRICE TO $250 FROM $220

JP Morgan has increased its target price for Quest Diagnostics Inc. from $220 to $250. This change in target price suggests an updated positive outlook for the company's stock by the financial institution. The specific reasons for this revised target are not detailed in …

Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $248.86, Implies 6% Upside

The average 12-month price target for Quest Diagnostics Incorporated (DGX) stock has been raised by analysts from $246.6 to $248.86, indicating an approximate 6% potential upside from its July 29th closing price. The consensus rating from 20 analysts remains a "Buy," with 9 Buys, …

Quest Diagnostics SVP Mark Delaney sells $376k in shares

Mark E. Delaney, SVP and CCO at Quest Diagnostics Inc. (NASDAQ: DGX), sold 1,600 shares for $376,288 on July 28, 2026, conducted under a Rule 10b5-1 sales plan. This transaction occurred as the stock neared its 52-week high, after a significant 12% gain. The …

Quest Diagnostics Incorporated (DGX) draws heavier weekly trading as trend stays active

The healthcare diagnostics stock extended its weekly advance, with volume and momentum readings adding confirmation rather than contradiction.

Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors despite daily gains

Quest Diagnostics Inc. (DGX) stock saw gains on Tuesday, rising 1.77% to $235.94, marking its second consecutive day of increases. Despite this daily advance and a positive overall market trend with the S&P 500 and Dow Jones also rising, Quest Diagnostics Inc. underperformed compared …

Quest Diagnostics Incorporated (DGX) volume expands in 52-week weekly setup

The diagnostics stock combined recent price strength with active trend confirmation as weekly turnover ran well above normal.